UNSPSC 85813833: Introduction of monoclonal antibody into joints, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into joints, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0U30M

UNSPSC 85813833 (Introduction of monoclonal antibody into joints, percutaneous approach) is a Commodity code with little recent activity aligned to its stated scope in state and local procurement. The recent opportunities tagged to this code reflect a significant mismatch between the code's nominal description—a clinical procedure—and the work actually being solicited, which centers on telehealth platforms, occupational health services, behavioral health programs, and public health infrastructure rather than orthopedic interventions.

The issuing bodies span a diverse mix of state health departments, county health authorities, regional health systems, municipal employees, and special districts. The Nevada Health Authority has appeared multiple times in the recent window (PACE operations and Rural Value Acceleration Network convener), and San Mateo Medical Center, various county sheriff's offices, and state health and human services commissions are active. The geographic spread includes California, Nevada, Colorado, Georgia, Florida, Arizona, Texas, Oregon, Illinois, Kansas, and the District of Columbia, with no concentration in any single jurisdiction. Representative solicitations include Inland Empire Health Plan's RFI for 24/7/365 virtual urgent care services (California, due October 31, 2026, RFI format), the Nevada Health Authority's RFP for PACE program operations across multiple service areas (due December 10, 2026, with capitation-based pricing ranging from $4,532.24 to $8,804.32 monthly per participant), and San Mateo Medical Center's RFP for cancer registry services (due November 6, 2026, three-year contract with local business preference). The code appears to serve as a catch-all taxonomy marker for diverse healthcare services delivery rather than reflecting the specific clinical procedure named—a structural signal worth monitoring for procurement categorization issues when evaluating this code's relevance to orthopedic or interventional service scopes.